when will retatrutide be approved available for weight loss? Retatrutide—A Game Changer in Obesity

Overall, these findings highlight a potential protective role of GLP-1 RAs in bladder health independent of diabetes status

Whether such changes represent a physiological adaptation to overall weight reduction or pose a risk for functional decline remains an unresolved issue [13, 14]

Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease (NAFLD), has seen its global prevalence surge from 25% between 1990 and 2006 to 38% between 2016 and 2019

Instead of stopping medication suddenly, some people may transition gradually to lower doses

Gentle Movement You do not need to run a marathon in your first week